VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,895,000 | +275.5% | 110,806 | +129.2% | 0.79% | +663.1% |
| Q4 2016 | $771,000 | -34.6% | 48,354 | -31.8% | 0.10% | -34.8% |
| Q3 2016 | $1,179,000 | +10.5% | 70,858 | +7.5% | 0.16% | -21.8% |
| Q2 2014 | $1,067,000 | -69.7% | 65,936 | -79.5% | 0.20% | -71.3% |
| Q3 2013 | $3,527,000 | +64.7% | 321,548 | +21.3% | 0.70% | +51.2% |
| Q2 2013 | $2,141,000 | – | 265,012 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |